FOXE1 and thyroid tumor: Our results revealed lower FOXE1 mRNA levels and absent protein expression in the patients’ thyroid tumours, when compared to matched adjacent normal and hyperplastic thyroid tissues, regardless of the FOXE1 mutation status, which is in agreement with data from The Cancer Genome Atlas (TCGA) [47,48].